Ligachem Bioscience Co., Ltd. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2006

Location

Daejeon South Korea

Primary Industry

Pharmaceuticals

About

Founded in 2006 and based in Daejeon, South Korea, Ligachem Bioscience Co., Ltd. is a research-oriented pharmaceutical company. The company was founded by its CEO, Kim Yong-ju. In January 2024, Lego Chem Biosciences raised KRW 550 billion in venture funding from Pan Orion. Following the transaction, Pan Orion will own a 4.93% minority stake in the company. The transaction includes 1.2 million shares previously owned by Lego Chem Biosciences' management. Ligachem's core technology, LigaChemistry, is a drug discovery platform used to develop new drug candidates in areas such as antibiotics, anti-fibrotics, immuno-oncology, and anticoagulants. The company also specializes in providing antibody-drug conjugates (ADCs) through its ConjuALL platform.

Current Investors

Atinum Investment, KB Investment, Yuanta Investment

Request a demo to show more

Primary Industry

Pharmaceuticals

Sub Industries

Pharmaceutical Research & Development

Website

www.legochembio.com

Company Stage

Mature

Total Amount Raised

Subscriber access only

Timeline of Key Events

Want to see the Timeline of Key Events?

Request a demo for full access to this profile.

Financials

Fiscal Year Ended
Revenue (USD)
% Revenue Growth (YoY)
Operating Income (USD)
Operating Margin
EBITDA (USD)
% EBITDA Margin
NET Income (USD)
% Net Margin

31 Dec 2011

78,887,440

(2,940,985,121)

(3728.1%)

(2,844,285,121)

(3605.5%)

(3,070,134,511)

(3891.8%)

31 Dec 2012

744,280,236

843.5%

(3,251,665,142)

(436.9%)

(3,176,531,142)

(426.8%)

(2,674,457,761)

(359.3%)

31 Dec 2013

839,824,813

12.8%

(6,259,743,563)

(745.4%)

(6,063,699,563)

(722%)

(5,835,328,224)

(694.8%)

31 Dec 2014

870,054,390

3.6%

(8,457,032,146)

(972%)

(8,113,143,146)

(932.5%)

(8,685,693,805)

(998.3%)

31 Dec 2015

1,788,474,514

105.6%

(8,048,858,624)

(450%)

(7,654,270,624)

(428%)

(8,237,854,945)

(460.6%)

31 Dec 2016

16,655,491,627

831.3%

(10,172,813,657)

(61.1%)

(8,021,897,657)

(48.2%)

(14,724,669,419)

(88.4%)

31 Dec 2017

22,056,557,550

32.4%

(9,842,081,174)

(44.6%)

(7,202,410,174)

(32.7%)

(12,933,665,235)

(58.6%)

31 Dec 2018

25,240,301,764

14.4%

(15,977,963,887)

(63.3%)

(13,197,953,887)

(52.3%)

(26,072,682,686)

(103.3%)

31 Dec 2019

57,500,138,690

127.8%

8,416,841,998

14.6%

12,281,606,998

21.4%

12,475,507,793

21.7%

31 Dec 2020

49,393,701,591

(14.1%)

(29,761,761,146)

(60.3%)

(26,767,337,146)

(54.2%)

(6,986,261,219)

(14.1%)

31 Dec 2021

31 Dec 2022

31 Dec 2023

Unlock the recent years of financials and more for Ligachem Bioscience Co., Ltd..

Request a demo to see more.

Employee Data

Want to see the Employee Count?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.